In Memoriam Remembering Professor Emeritus and Rabbi Neil S. Hecht, Renowned Jewish Law Scholar Read more
Health Law CARB-X Receives Global Funding in Fight Against Antimicrobial Resistance August 23, 2023 CARB-X Can we Prevent Antibiotic Resistance? November 21, 2022 Health Law CARB-X Funds Sutrovax to Develop a New Vaccine to Prevent Group A Streptococcal Infections September 3, 2019 Health Law Germany Joins CARB-X Partnership in the Fight Against Deadly Drug-Resistant Superbugs March 14, 2019 CARB-X CARB-X Expands its Global Accelerator Network February 26, 2019 Health Law CARB-X Backs Forge Therapeutics January 4, 2019 BU Law News CARB-X Calls for New ‘Open Science’ Era in Antibacterial Innovation September 24, 2018 Health Law BU Law Professors Plan to Study Impact of Biopharmaceutical Funder CARB-X September 21, 2018 Health Law CARB-X Funds SciBac to Develop a Microbe Drug that Kills C. Difficile Superbugs July 31, 2018 BU Law News CARB-X Funds Summit Therapeutics to Support Development of a New Class of Antibiotic to Treat Gonorrhoea Superbug July 10, 2018 Posts navigation 123
Health Law CARB-X Funds Sutrovax to Develop a New Vaccine to Prevent Group A Streptococcal Infections September 3, 2019
Health Law Germany Joins CARB-X Partnership in the Fight Against Deadly Drug-Resistant Superbugs March 14, 2019
Health Law BU Law Professors Plan to Study Impact of Biopharmaceutical Funder CARB-X September 21, 2018
Health Law CARB-X Funds SciBac to Develop a Microbe Drug that Kills C. Difficile Superbugs July 31, 2018
BU Law News CARB-X Funds Summit Therapeutics to Support Development of a New Class of Antibiotic to Treat Gonorrhoea Superbug July 10, 2018
